Nov 8th… vote as if your life depends on it.

moralterrorist

Legislature believes that they can legislate a cure to mental illness ?

Law to cap opioid prescriptions goes into effect Friday

http://wtnh.com/2016/06/29/law-to-cap-opioid-prescriptions-goes-into-effect-friday/

HARTFORD, Conn. (WTNH) — If you have an opioid prescription, things are about to change. A bill that will shorten prescriptions to just seven days has been approved and will go into effect Friday.

Mothers held photos, telling tragic stories of losing children to heroin, an addiction they say started with pain pills, as Governor Malloy signed a new law hoping to cut down on the number of opioid pain pills on the street. Starting Friday, the new Connecticut law restricts doctors and only allows them them to prescribe seven days worth of opioid pain medicine at a time.

Sen. Dante Bartolomeo representing Middletown and Meriden, says she believes doctors were way over-prescribing the pain pills.

“We have been hearing that often if a child is going to have their wisdom teeth out, that is something that is really common, they will give a 30-day supply and there is just no need for that,” said Bartolomeo.

Dr. Craig Allen is the Medical Director at Rushford. He believes the lawmakers are on the right track and it is a step in the right direction as they’re able to get as many loose pills as they can off the street.

“The research shows that 3 to 5 days worth of these opioid pain medications is generally enough for a surgical procedure,” said Allen.

Dr. Allen says if there is still significant pain after 3 to 5 days, the patient should see the doctor anyway, not take more pain pills, because the pain pills are dangerously addictive, and can hide bigger health problems.

“It’s not masked by a larger prescription of pills, which someone may take or they may not take and they go on the shelf and they go in the medicine cabinet and then they get out on the street,” said Allen.

The law also allows all first responders to carry Narcan, a life-saving drug for someone overdosing on heroin.

AG locked in prolonged battle with drug companies

AG locked in prolonged battle with drug companies

http://www.concordmonitor.com/NH-attorney-general-battle-with-drug-companies-3424021

It sounds like to me that the AG of  NH believes that the doctors in NH are not bright enough to know that OPIATES have a POTENTIAL to be addicting.  And these same doctors have been convinced by some marketing program to disregard what they should have learned in medical school about the potential for opiates to be addicting.  Maybe the AG should be asking the NH medical licensing board to suspend/revoke the medical licenses of all of these prescribers ?

One year after the state attorney general’s office filed subpoenas against five large drug companies to discover how addictive painkillers have been marketed in the state, the pharmaceutical giants have handed over nothing more than legal briefs.

“They’ve yet to produce one piece of paper,” said Assistant Attorney General James Boffetti, who is heading up the state’s investigation against the drug companies.

Boffetti’s three-person team is badly outnumbered by lawyers representing the pharmaceutical companies as they fight to get access to internal company documents. The attorney general’s office announced last month it was narrowing its probe to just look at Purdue Pharma LP, which manufactures the opioid OxyContin.

In a lawsuit filed in Merrimack County Superior Court, the attorney general’s office accuses Purdue of engaging in deceptive marketing, misrepresenting the “risks and benefits of long-term opioid use for chronic pain.”

“Purdue sales representatives continue to make sales visits to New Hampshire doctors during which they misleadingly portray or omit the risk of addiction,” wrote Boffetti, adding that the company made 217 marketing visits to the state in 2014, the most recent year with available data.

 

Boffetti characterizes the legal fight as a “David and Goliath” situation. The state – without any outside assistance – has three lawyers working on the investigation. The pharmaceutical companies have 19.

“They have a virtual army of lawyers, from New Hampshire and outside,” said Boffetti, who is charge of the state investigation. “It’s not just their lawyers, they have the resources of their entire law offices.”

Boffetti’s old boss is one of those lawyers. Former New Hampshire attorney general Michael Delaney is representing Endo Pharmaceuticals Inc., which recently settled with the state of New York over deceptive marketing practices of an opioid it manufactured, Opana ER.

Delaney served as attorney general in New Hampshire from 2009 to 2013.

Boffetti said his office needs help to sort through reams of documents if they come in.

“The volume of stuff to come in will be enormous,” he said.

PHARMA PROBE The issue: Purdue Pharma is accused of engaging in deceptive marketing, misrepresenting the “risks and benefits of long-term opioid use for chronic pain.” The company made 217 marketing visits to New Hampshire in 2017.AG’s request: The attor

Boffetti and his team are after internal documents from Purdue Pharma they hope will shed light on how prescription opioids were marketed to doctors and health providers in New Hampshire.

The current legal fight is whether the attorney general’s office can hire outside help.

All of the drug companies have refused to turn over any internal documents, as long as the attorney general’s office works with hired counsel – Cohen Milstein – a firm that has litigated similar cases against the pharmaceutical industry.

Lawyers representing the drug companies have argued Cohen Milstein has an inherent bias against them because it will only get paid if the state takes future legal action against the drug companies. A Merrimack County Superior Court judge recently sided with the state, but the drug companies are refusing to budge.

Lawyers have appealed the decision to the state Supreme Court and argue they should not have to turn over any internal documents until that decision is handed down.

“They don’t want us to know, that’s for sure,” Boffetti said. “We can have no resources; they’ll do everything they can to prevent us from seeing the documents.”

Elsewhere, light is starting to shine on Purdue’s marketing practices. An ongoing Los Angeles Times investigation into Purdue Pharma revealed the company marketed OxyContin as a pill to provide users with 12 hours of pain relief, despite the company’s own studies that showed the drug wore off hours early in many participants, leaving withdrawal symptoms and cravings.

The Times investigation found that Purdue knew OxyContin didn’t last 12 hours before the drug went onto the market.

Nevertheless, the drug maker not only stuck to their claim that the 12-hour window worked, it advised doctors to prescribe stronger doses of the drug if patients complained they weren’t getting the full window of relief, the Times reported.

Furthermore, the paper’s investigation found that Purdue knew of doctors who were overprescribing vast amounts of OxyContin potentially headed for the black market – and frequently did not share that information with law enforcement or cut off the supply.

Purdue Pharma keeps its own database of over 1,800 doctors it suspects are overprescribing, but does not alert law enforcement or medical authorities.

Boffetti said he can’t comment on whether similar overprescribing of OxyContin has gone on in New Hampshire, as the investigation is ongoing. But he said getting internal company documents will be an important piece of that.

“We need to get to the bottom of what they did so we can figure out if they violated the law,” he said.

These types of accusations aren’t new to Purdue. The Connecticut-based company agreed in 2007 to pay $600 million in federal fines after admitting it misled doctors and patients by understating OxyContin’s addictiveness. A federal prosecutor said at the time that the marketing had resulted in rising crime rates, teenage drug addiction and death, among other public health concerns.

Annual revenue at Purdue is about $3 billion, mostly due to OxyContin sales, according to Forbes. The company has made more than $35 billion since releasing OxyContin in 1995.

(Ella Nilsen is at 369-3322, enilsen@cmonitor.com or on Twitter @ella_nilsen.)

This Is Why People Hate Congress

cryingeyevote

‘This Is Why People Hate Congress’: What We Heard This Week

http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/59126

“You make it too complicated, you’re going to lose physicians.” — Thomas Eppes, Jr, MD, of Central Virginia Family Physicians, in Lynchburg, Va., on implementation of MACRA.

“This is just one of the most unfair things I’ve ever seen.” — Clarey Dowling, MD, a primary care physician in rural Tennessee, on the state Medicaid program’s insistence that he pay back $200,000 because he isn’t board certified.

“We have clearly heard from arthritis patients in both on-reserve and in urban settings that negative healthcare experiences in specialty care leads to a decision to disengage from further contact with rheumatologists.” — Cheryl Barnabe, MD, of the University of Calgary in Canada, on the prevalence of inflammatory arthritis and healthcare use among First Nations people in Canada.

“If you understand the mechanisms for a particular molecular target, you can develop devices that use electrons to replace drugs.” – Kevin J. Tracey, MD, of the Feinstein Institute for Medical Research in Manhasset, N.Y., on vagus nerve stimulation for rheumatoid arthritis.

“Although cigarettes are still the most commonly used tobacco product, we are seeing the use of other forms of tobacco increasing, which is why it is important to address all forms of tobacco use among adults, not just cigarettes.” – Brian A. King, PhD, of the CDC’s Office on Smoking and Health, on survey results showing that one in four adults still use tobacco products.

“This is why people hate Congress. This is why people hate Washington.” — Sen. Tim Kaine (D-Va.) on the Senate’s inability to pass a Zika funding bill.

“There’s that space opera I always wanted to write.” — Lydia Kang, MD, a novelist and internal medicine physician in Omaha, Neb., joking about her future plans as a writer.

AMA Principles of Medical Ethics

Professing the Values of MedicineThe Modernized AMA Code of Medical Ethics

http://jama.jamanetwork.com/article.aspx?articleid=2534495

The word profession is derived from the Latin word that means “to declare openly.” On June 13, 2016, the first comprehensive update of the AMA Code of Medical Ethics in more than 50 years was adopted at the annual meeting of the American Medical Association (AMA). By so doing, physician delegates attending the meeting, who represent every state and nearly every specialty, publicly professed to uphold the values that are the underpinning of the ethical practice of medicine in service to patients and the public.

The AMA Code was created in 1847 as a national code of ethics for physicians, the first of its kind for any profession anywhere in the world.1 Since its inception, the AMA Code has been a living document that has evolved and expanded as medicine and its social environment have changed. By the time the AMA Council on Ethical and Judicial Affairs embarked on a systematic review of the AMA Code in 2008, it had come to encompass 220 separate opinions or ethics guidance for physicians on topics ranging from abortion to xenotransplantation. The AMA Code, over the years, became more fragmented and unwieldy. Opinions on individual topics were difficult to find; lacked a common narrative structure, which meant the underlying value motivating the guidance was not readily apparent; and were not always consistent in the guidance they offered or language they used.

The systematic review and revision of the AMA Code was a multiyear, iterative enterprise that was informed, at each stage, by input from stakeholders inside and outside the medical profession. The modernized AMA Code2 is grounded in the AMA Principles of Medical Ethics (Box), which are not laws, but standards of conduct that define the essentials of ethical behavior for physicians.

AMA Principles of Medical Ethics
  1. A physician shall be dedicated to providing competent medical care, with compassion and respect for human dignity and rights.

  2. A physician shall uphold the standards of professionalism, be honest in all professional interactions, and strive to report physicians deficient in character or competence, or engaging in fraud or deception, to appropriate entities.

  3. A physician shall respect the law and also recognize a responsibility to seek changes in those requirements which are contrary to the best interests of the patient.

  4. A physician shall respect the rights of patients, colleagues, and other health professionals, and shall safeguard patient confidences and privacy within the constraints of the law.

  5. A physician shall continue to study, apply, and advance scientific knowledge, maintain a commitment to medical education, make relevant information available to patients, colleagues, and the public, obtain consultation, and use the talents of other health professionals when indicated.

  6. A physician shall, in the provision of appropriate patient care, except in emergencies, be free to choose whom to serve, with whom to associate, and the environment in which to provide medical care.

  7. A physician shall recognize a responsibility to participate in activities contributing to the improvement of the community and the betterment of public health.

  8. A physician shall, while caring for a patient, regard responsibility to the patient as paramount.

  9. A physician shall support access to medical care for all people.

The AMA Principles are followed by chapters that include opinions that represent interpretations of relevant Principles as they apply to a specific matter of ethical import in medicine. To make guidance easier to locate, opinions were reorganized into 11 more intuitive topical chapters (eTable in the Supplement). In addition, a consistent format was constructed to ensure that each opinion succinctly articulates the core ethical values on which guidance is based, defines the broad context in which guidance is relevant, and sets out specific ethical responsibilities in the form of practical actions for individual physicians or the profession as a whole to take. For example, the opinion on “privacy in health care,” which provides guidance based on interpretations of AMA Principles 1 and 4, reads as follows:

  • “Protecting information gathered in association with the care of the patient is a core value in health care. However, respecting patient privacy in other forms is also fundamental, as an expression of respect for patient autonomy and a prerequisite for trust.

  • Patient privacy encompasses a number of aspects, including personal space (physical privacy), personal data (informational privacy), personal choices including cultural and religious affiliations (decisional privacy), and personal relationships with family members and other intimates (associational privacy).

  • Physicians must seek to protect patient privacy in all settings to the greatest extent possible and should:

    • (a) Minimize intrusion on privacy when the patient’s privacy must be balanced against other factors.

    • (b) Inform the patient when there has been a significant infringement on privacy of which the patient would otherwise not be aware.

    • (c) Be mindful that individual patients may have special concerns about privacy in any or all of these areas.”

Throughout the modernized AMA Code, the terms must, should, and may are used to distinguish different levels of ethical obligation and are explicitly defined so as to minimize misinterpretation by physicians and the patients they serve. Must indicates that an action is a near-absolute obligation. For example, in the opinion on “financial relationships with industry in continuing medical education,” physicians must ensure that the profession independently defines the goals of physician education, determines educational needs, and sets its own priorities for continuing medical education. Should indicates that an action or obligation is strongly recommended, absent special circumstances or considerations in which there is latitude for physician judgment and discretion. For example, in the opinion on “preventing, identifying, and treating violence and abuse,” physicians should routinely inquire about physical, sexual, and psychological abuse as part of the medical history. May indicates that an action is ethically permissible when qualifying conditions set out in an opinion are met. For example, in the opinion on “confidentiality,” physicians may disclose personal health information without the specific consent of the patient to other health care personnel for purposes of providing care or for health care operations.

In the revision, when 2 or more existing opinions provided substantially similar guidance on closely related topics, key content was consolidated into a single, more comprehensive opinion. For example, there were 6 separate opinions on ethical responsibilities in managing medical records, and these opinions overlapped significantly in content. The unique guidance of the individual opinions was distilled to create an overarching opinion that integrates guidance into a single source and eliminated redundancy. The result is a more streamlined AMA Code with 161 opinions.

The modernized AMA Code reconciles guidance across different opinions by ensuring that preferred definitions and consistent terminology are used—eg, replacing (health care) proxy with surrogate wherever guidance addresses situations that involve patients who do not have decision-making capacity. Similarly, particular ethics concepts, such as respect for patient autonomy, are normalized as much as possible and presented in individual opinions so that key concepts and terms are invoked in a transparent and clearly consistent way across opinions.

With the adoption of the modernized AMA Code, ethics guidance in this newest edition is offered in a clear, consistent, and compelling manner, which is essential to helping current and future physicians understand and uphold their obligations as trusted professionals. By upholding these obligations in the care of patients and communities, the medical profession is publicly recommitting itself to core values that endure in the face of ongoing change in medical science and a diverse society.

Proper medication cannot disqualify a person for a job ?

What? He failed a drug test … so how can he sue under the ADA?

www.hrmorning.com/failed-drug-test-sue-ada/

The moral of this story: Like the feds, the courts want to see you do everything in your power to work with disabled individuals. 

If you can’t show that you did everything in your power to help those with disabilities perform their jobs, you’re going to have a lot of difficulty getting a discrimination claim thrown out of court. That’s the legal landscape employers are now facing.

Driver was on amphetamine

Here’s an example of how tricky it is to comply with the ADA: John Lisotto was denied a position as a truck driver at New Prime Inc., a fuel hauler, because he failed the company’s medical exam during the hiring process.

Lisotto suffered from narcolepsy, and took a prescribed amphetamine — Dexedrine — to manage the sleep disorder.

In anticipation of the drug test, Lisotto submitted a letter from his physician to New Prime.

The letter said:

“the prescribed medication would not adversely affect [Lisotto’s] ability to safely operate a commercial motor vehicle as [Lisotto] had for many years been driving commercial trucks safely … while taking [Dexedrine] and had experienced no problems with narcolepsy.”

Prime’s medical examiner told Lisotto that he needed to be off Dexedrine for at least one month. He also told Lisotto that Provigil was the only medication for narcolepsy that Prime would accept.

After that, Lisotto’s drug test results came back and he was told by one of Prime’s nurses that he couldn’t work for Prime because of his positive test result for Dexedrine. He was then told to return home and take Provigil for six weeks to see how it would affect him.

Lisotto did exactly that.

But when he reached out to New Prime again to inquire about becoming a driver, he was shut down.

Eventually, he received a letter from New Prime’s medical review officer that said:

“Even though you had a prescription for amphetamines, in my opinion you have a disqualifying medical condition since narcolepsy is a safety concern.”

ADA claim

Lisotto then filed a disability discrimination lawsuit under the ADA.

New Prime fought to get his lawsuit dismissed, claiming that Lisotto was required to first seek administrative recourse with the Federal Motor Carrier Safety Administration, which is tasked with resolving “conflicts of medical evaluation” where the physician for a driver and the physician for the motor carrier disagree on a driver’s qualifications.

But the court said there was no such disagreement here. It said both parties’ physicians indicated that as long as Lisotto took proper medication, he appeared qualified.

Instead, it said the breakdown occurred when New Prime’s medical review officer failed to communicate with Lisotto’s physician to determine whether there was a legitimate medical reason to take his failed drug test at face value.

In other words, the biggest problem for New Prime was it cut off talks with Lisotto’s doctor and relied solely on the failed drug test to deny him a job without looking deeper into whether he could still do the job.

As a result, the court ruled Lisotto’s ADA lawsuit could proceed despite his failed drug test, which means New Prime is facing a costly lawsuit or settlement.

Cite: Lisotto v. New Prime Inc.

New analysis recommends responsible prescription of opioids to pain patients

New analysis recommends responsible prescription of opioids to pain patients

https://www.sciencedaily.com/releases/2016/07/160713102505.htm

A recent review and analysis suggests that some policies restricting opioid prescriptions to curb overdose deaths could be harming those who need them the most: pain patients.

“Negative outcomes of unbalanced opioid policy supported by clinicians, politicians, and the media” was published in the latest issue of the Journal of Pain & Palliative Care Pharmacotherapy. Co-authored by Willem Scholten and Jack E. Henningfield, the article suggests that the opioid epidemic has at times been misrepresented by politicians and the media.

“There is a disturbing tendency among doctors, politicians and the media in the US to be preoccupied by certain aspects of opioids: their benefits are questioned and their risks sensationalized,” said Scholten, a medicine and controlled substances consultant. This, he says, can lead people to lose sight of the bigger picture of pain management.

The article advocates balanced and comprehensive drug control policies that are based on accurate evaluation of the science and epidemiology, rather than what is sometimes portrayed in the mainstream media. The authors provide a number of recommendations for responsible prescription of opioids, such as regular assessment of the patient’s pain and functioning and informing the patient and his/her caregivers about the correct use of prescribed medicines, as well as how to safely dispose of unused medicines.

Scholten and Henningfield said while opioid overdoses are on the rise in the United States, this is not the case in places such as Europe. While they encourage the creation of policies minimizing the harm of opioids, they suggest doing so in the right context and in a rational way.

“Blocking access to prescription opioids should not have a negative impact on pain treatment or worsen overall harmful substance use,” Scholten said.


Story Source:

The above post is reprinted from materials provided by Taylor & Francis. Note: Materials may be edited for content and length.


So… you want to see change ?

votingboothlawsuit-clipart-judge-cartoon1

Every week I see a few new Face Book pages focused on chronic pain and at least one new petition to the White House, Congress are some bureaucratic entity.  While all these groups are fighting for the same final goal… no one seems to understand that thousands of voice – not in concert – just sounds like a ROAR of NOISE.

All those dozens of petitions… and most get a few thousand signatures at most.. the only one that I know about that got over 100,000 signatures was to recall the head of the DEA.. and that was months ago.. and to the best of my knowledge the DEA has the same leader.

Just look at the many groups that should be advocating/protecting those in the chronic pain community.

AARP… they are suppose to look out for those 50+… estimated guess is that at least HALF of the reported 100-116 million chronic pain pts… would fall into the 50+ age range.. and where is the AARP speaking up for their members and/or age group they are suppose to be supporting ?

ACLU… is suppose to defend civil liberties… other than taking the AG and Medical Licensing board of Indiana to court over emergency rule of mandatory urine testing for all pts taking opiates. Turned out that was a violation of the 4th Amendment

ADA… the Civil Rights Division of the DOJ, plus there are many states that have their own ADA laws. Nearly all of the activity I have seen enforcing this law has been dealing with those people who are HIV+, ethnic groups and those in the LGBT community.

The legal/attorney community, how many times a day do you see an attorney advertising on TV, wanting to sue someone for causing a accident and causing someone else pain and suffering. Yet, I have not seen the first incident of an attorney suing a healthcare professional INTENTIONALLY causing a pt pain and suffering because they reduced the pt’s dose and/or refused to fill their prescriptions.

40+ Governors to sign Massachusetts-inspired opioid prescription compact

Included in that number is Trump’s VP pick Gov Pence.. but don’t that let you decide that Hillary is the one… she has endorsed the one cent per mg opiate tax proposed by WV’s Senator. Everyone at the Federal/State level seems hell-bent on making the CDC opiate guidelines the “law of the land”.

If there are 100-116 million chronic pain pts out there, IMO.. they need to get their act together. The chronic pain community doesn’t need more leaders/advocates than they have those willing to follow.

Maybe it is time for a new “silent majority”… a new T.E.A. party (Tortured Enough Already) and the first order of business is to get organized and vote all the incumbents out of office with this fall’s election.

torturedIf the 99% that normally get reelected… get reelected.. the path to reduced opiates for all chronic pain pts has been put in place… another two years allowing that plan to be implemented may make it too long to reverse changes already in place.

They don’t feel your pain… throwing them out of office and letting them find a “real job” will be the first step in sharing your pain.  Their replacements will be so paranoid that they will start listing to their constituents… because if their constituents cleaned house once… it can be done again..

You can register to vote by mail and vote by mail… The only valid reason you can have for not voting is if you can’t make it to your mailbox or you don’t  have the money to buy two postage stamps.

Vote as if your life depended upon it

The only other alternative is to start suing to get your life back, I believe that voting will be the fastest and least expensive path to take.

 

 

Bureaucrats create rules, prescribers follow rules, DEA does raids because rules cause deaths

desertedisland

DEA, state crack down on pain doctor over opiate prescriptions, citing 18 deaths

http://www.seattletimes.com/seattle-news/health/dea-state-crack-down-on-pain-doctor-over-opiate-prescriptions-citing-18-deaths/

The state of Washington many years ago – as a cost saving measure – mandated that Methadone be used for Medicaid chronic pain pts.  Methadone has proven to be a very good medication for many chronic pain pts, however prescribers who are not very familiar with the idiosyncrasies in the dosing of Methadone over other opiates can be fatal to pts. It has been documented that 2-4 pts will die within TWO WEEKS of being first prescribed Methadone. So the deaths within Dr Li practice could be from the large prescribing of Methadone to pts.. as mandated by Medicaid by those politicians that like to practice medicine without any medical knowledge.  Likewise, the bureaucrats rescinded the practice’s ability to participate in Medicaid and thus these people who are Medicaid because they have little/no financial resources.. are given the alternative to PAY CASH FOR ALL THEIR MEDICATIONS.

Have you also noticed that the DEA has seemed to increase their actions on multi-location clinics and/or chain clinics and they are targeting ONE PRESCRIBER out of all working for the chain, and the clinics are allowed to remain open with the remaining prescribers.  Are they targeting the prescriber with the MOST FINANCIAL ASSETS and this is more about civil forfeitures of the prescriber’s assets to benefit the DEA.. than anything actually deal with anything else?

State health officials have suspended the license of Dr. Frank Li, medical director for a chain of eight pain clinics in Washington that serves as many as 25,000 patients. He also can’t bill Medicaid.

A Seattle doctor who heads a chain of eight Washington pain clinics has been barred from practicing medicine after state regulators charged that he failed to properly monitor prescription use of powerful opiates, possibly contributing to at least 18 deaths since 2010.

The Washington state Medical Commission on Thursday suspended the license of Dr. Frank D. Li, 48, medical director of Seattle Pain Centers, and revoked the agreement that allows five physician assistants to practice under his authority.

Officials also said they have either started investigations or filed complaints regarding more than 40 doctors and other health-care providers who have worked for Seattle Pain Centers since 2013. And the state agency that oversees Medicaid revoked Li’s ability to bill for services.

Find help

Seattle Pain Centers’ patients should seek advice from their primary-care providers and insurance plans about finding a new source of pain management, officials said Thursday.

Call the Washington Recovery Helpline at 1-866-789-1511, or visit warecoveryhelpline.org

Washington State Department of Health

 At the same time, diversion investigators with the federal Drug Enforcement Administration went to Li’s Renton clinic Thursday. DEA spokeswoman Jodie Underwood would not comment on the purpose of the visit.
Li was not at the site and did not respond to Seattle Times calls Thursday seeking comment. He has 14 days to respond to the state charges and request a hearing.

The moves could affect a clinic he operates in Beverly Hills, Calif., as well.

The crackdown in Washington will all but shutter clinics in eight cities — Seattle, Tacoma, Olympia, Poulsbo, Vancouver, Renton, Everett and Spokane — that serve at least 12,000 Medicaid and Medicare patients across the state, and perhaps as many as 25,000 people, including many with chronic pain.

The sites will stay open, at least for now, said Micah Matthews, deputy director of the Washington state Medical Quality Assurance Commission (MQAC).

“There shouldn’t be an immediate disruption,” Matthews said. “We’re planning for the worst possible scenario, but we don’t expect the clinics will be immediately shut down.”

Patients will be able to obtain prescriptions for now. Seattle Pain Centers employs at least three other medical doctors, according to the firm’s website, whose licenses remain active, and other providers, including advanced registered nurse practitioners, ARNPs, who can continue to prescribe medication. But because Medicaid payment won’t be honored, patients will have to pay for the drugs themselves.

State officials urge patients to check with their primary-care providers about finding another source for pain care.

The medical commission’s statement of charges, dated Wednesday but issued Thursday, alleges that Li committed unprofessional conduct in violation of state regulations for chronic, non-cancer pain management, including rules designed to prevent opiate abuse, overdose and death. It also states that he failed to conduct proper patient evaluation, to provide informed consent to patients or their families, and to conduct proper reviews and consultations for opiate therapy.

The actions may have contributed to the deaths of 18 Medicaid patients seen by Seattle Pain Centers between 2010 and 2015 — and possibly dozens more, Matthews said.

Seattle Pain Centers patients were given opiates inappropriately, with little supervision, in amounts that may have sent the powerful medications onto the street to be sold, officials said.

“I guess what I would call it is classic ‘pill mill’ behavior,” Matthews said.

Thirteen complaints targeting Li and Seattle Pain Centers have been filed with the medical commission since 2010, records show. Eleven were closed after no violations could be verified, officials said.

But two complaints filed in 2015 remain open: one from the Health Care Authority (HCA) and one from the state Attorney General’s Office.

 

Both the HCA complaint and a May 2015 complaint filed by the state Medicaid Fraud Control Unit, a division of the Attorney General’s Office, detailed problems with Li’s practice.

Issues included hiring minimally trained staff and allowing them to bill under the names of established providers at the clinic; excessive use of urine drug screens to maximize profit; and failure to properly monitor a high number of complex patients.

The new actions reflect only the latest concerns regarding Li.

In 2013, officials with the state Department of Labor and Industries (L&I) denied Li’s application to prescribe drugs for the workers’ compensation program. That decision, officials said, was based on “noncompliant” prescribing practices and substandard care of a patient who died of an overdose. Li withdrew his application before L&I officials could report the denial, the charging statement said.

In addition, Li has not been able to bill Apple Health, the state Medicaid program, for laboratory payments since February 2015, when HCA officials barred payments to Northwest Analytics, the lab he operated, amid suspicions of fraud related to unnecessary urine screens.

On Thursday, HCA also terminated Li’s core-provider agreement, which allows him to bill Medicaid for clinic services. That move prevents other providers who work for Li from billing Medicaid, too. They can reapply for participation, an HCA spokeswoman said.

Li’s status with Medicare had not changed Thursday.

Washington’s actions soon could be followed by California, where Li has been licensed in good standing since 1999.

“That would immediately trigger us, we would be notified and then we would take a look at him as well and take any appropriate action,” said Cassandra Hockenson, a spokeswoman for California’s medical board.

18 deaths

The Washington attorney general’s complaint documented the unexpected overdose deaths of 18 Medicaid patients seen by Seattle Pain Centers between January 2010 and April 2015, according to a copy obtained by The Seattle Times. Patients died within days or weeks of filling prescriptions from the clinics, the investigation found.

Those deaths were included in the medical commission’s statement of charges, which found that acute drug intoxication was a cause or likely contributing factor in 16 of the deaths. One patient died in a car accident and another died from a stroke, but both received opiates from Seattle Pain Centers and had “multiple, serious health conditions” that clinic providers disregarded during opiate therapy.

“(The) medical records reveal an egregious pattern of substandard medical care,” the charges said.

The state medical commission has been investigating Li and his clinics for more than a year, but only received confirming evidence, including a required outside expert’s opinion, in mid-June, Matthews said.

“It may have been available a year ago, but it wasn’t available to us,” he said.

The deaths included Becky Gene Rae Kruse, 58, of Everett, a grandmother of three who had fibromyalgia and struggled most of her life with chronic pain and addiction.

Kruse, who is listed as “Patient J” in the charges, died April 7, 2013, after an overdose of drugs including painkillers methadone, hydromorphone and tramadol, plus trazodone, an anti-anxiety medication, the charges state.

Her daughter, Megan Sargent-Everett, 33, of Spokane, found Kruse collapsed on the bathroom floor, with the sink faucet still running, a police report said.

Six days before her death, Kruse had filled a prescription for 90 4-milligram hydromorphone pills, also known as Dilaudid. It was written by an ARNP at the Everett Seattle Pain Centers clinic — which was within walking distance of Kruse’s apartment.

“We don’t think it was intentional,” said Nicole Ellis, 43, of Everett, Kruse’s sister. “She had her coffee mug half full. It really caught us off guard.”

The family was well aware of Kruse’s past problems, but Ellis, who saw Kruse at least once a week, said she seemed like she was doing better.

“Had it happened years ago, it wouldn’t have shocked us at all. But she was looking pretty good, gaining weight,” Ellis recalled. “I really don’t know for sure why she had so many drugs in her system.”

Patients like Kruse need careful monitoring by experienced pain-medication providers, Ellis said.

“They’re real people. Their lives are precious, and they’re not to be thrown away,” she said.

Infrastructure lacking

Li is a board-certified pain-management specialist licensed since 1999 in California and since 2008 in Washington state. He started the Seattle Pain Center Medical Corp. that year, just after a state panel approved new guidelines regarding treatment of non-cancer chronic pain. Strict new laws took effect in 2012.

The laws require doctors to incorporate safeguards into their practices, including close supervision, to minimize the potential for abuse and diversion of controlled substances, including opiate painkillers.

Li didn’t heed those safeguards, officials said, even as he expanded the number of centers across the state, growing to seven, then eight sites. Li sought out what he described as the “most difficult pain patients,” the attorney general’s complaint said.

“But he failed to ensure that SPC (Seattle Pain Centers) had the infrastructure and qualified pain management specialists necessary to serve the large numbers of complex patients referred to his practice,” it stated. “Instead, Dr. Li’s rapid expansion of SPC’s clinical practice placed the care of those ‘most difficult pain patients’ in the hands or providers who were not qualified or able to care for such patients.”

 

Human rights… in the eye of the beholder ?

condemnhumanrightsusausahumanrights